NVCR - NovoCure Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

NovoCure Limited

Full Time Employees598

Key Executives

NameTitlePayExercisedYear Born
Mr. William F. DoyleExec. Chairman1.61MN/A1962
Mr. Asaf DanzigerPres, CEO & Director1.62MN/A1966
Prof. Yoram PaltiFounder & CTO282.51kN/A1938
Mr. Wilhelmus C. M. GroenhuysenChief Financial Officer1MN/A1958
Mr. Pritesh ShahChief Commercial Officer1.09M1.11MN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Corporate Governance

NovoCure Limited’s ISS Governance QualityScore as of July 29, 2019 is 4. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.